Anthem Biosciences IPO Date, Review, Price, Allotment Details

Anthem Biosciences IPO Details

Anthem Biosciences IPO Market Lot

The Anthem Biosciences IPO minimum market lot is 26 shares with ₹14,820 application amount. The retail investors can apply up-to 13 lots with 338 shares of ₹1,92,660 amount.

Anthem Biosciences IPO Dates

The Anthem Biosciences IPO date is July 14 and the close date is July 16. The Anthem Biosciences IPO allotment will be finalized on July 17 and the IPO listing on July 21.

Promoters of Anthem Biosciences IPO

The promoters of the company are Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj.

About Anthem Biosciences IPO

Anthem Biosciences Limited, founded in 2006, is one of the growing innovation-driven and technology-focused Contract Research, Development and Manufacturing Organizations (“CRDMO”) with end-to-end operations covering drug discovery, development, and manufacturing. Anthem Biosciences is one of the few companies in India with integrated capabilities in New Chemical Entities (NCE) and New Biological Entities (NBE) throughout drug discovery, development, and commercial manufacturing.

Anthem Biosciences is a one-stop service provider engaged in serving a wide range of customers, including emerging biotech companies and large pharmaceutical firms around the world. The company is involved in the manufacturing of specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company has supplied to over 150 customers, from small biotech to large pharmaceutical companies, as of March 31, 2024. Currently, the company has a team of 600 employees, including medicinal chemists, microbiologists, molecular biologists, biochemists, and chemical engineers.

Anthem Biosciences IPO Company Financial Report

The company reported revenue of ₹1,930.29 crores in 2025 against ₹1,483.07 crore in 2024. The company reported profit of ₹451.26 crores in 2025 against profit of ₹367.31 crores in 2024.

Amount ₹ in Crores

Anthem Biosciences IPO Valuation – FY2025

Check Anthem Biosciences IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

Peer Group Comparison

Objects of the Issue

• The Company will not receive any proceeds from the Offer (the “Offer Proceeds”) and all the Offer Proceeds will be received by the Selling Shareholders after deduction of Offer related expenses and relevant taxes thereon, to be borne by the respective Selling Shareholders.

Anthem Biosciences IPO Review

• IPO Watch – May Apply
• Canara Bank –
• DRChoksey FinServ –
• Emkay Global –
• Hem Securities –
• IDBI Capital –
• Marwadi Shares –
• Nirmal Bang –
• SBICAP Securities –
• Sharekhan –
• SMC Global –
• Sushil Finance –
• Swastika Investmart –
• Ventura Securities –
• Geojit –
• Reliance Securities –
• Capital Market –
• BP Wealth –
• ICICIdirect –
• Choice Broking –

Anthem Biosciences IPO Registrar

KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/

IPO Lead Managers aka Merchant Bankers

• Jm Financial Limited
• Citigroup Global Markets India Private Limited
• J.P. Morgan India Private Limited
• Nomura Financial Advisory And Securities (India) Pvt Ltd

Company Address

Anthem Biosciences Limited
No. 49, F1 & F2, Canara Bank Road
Bommasandra Industrial Area, Phase 1,
Bommasandra,
Bengaluru, Karnataka, 560099
Phone: +91 080 6672 400
Email: [email protected]
Website: https://www.anthembio.com/

Anthem Biosciences IPO FAQs